Correlation Between Entia Biosciences and PreveCeutical Medical

Can any of the company-specific risk be diversified away by investing in both Entia Biosciences and PreveCeutical Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entia Biosciences and PreveCeutical Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entia Biosciences and PreveCeutical Medical, you can compare the effects of market volatilities on Entia Biosciences and PreveCeutical Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entia Biosciences with a short position of PreveCeutical Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entia Biosciences and PreveCeutical Medical.

Diversification Opportunities for Entia Biosciences and PreveCeutical Medical

-0.37

Correlation Coefficient

Entia Biosciences  PreveCeutical Medical

Very good diversification

The 3 months correlation between Entia and PreveCeutical is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Entia Biosciences and PreveCeutical Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PreveCeutical Medical and Entia Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entia Biosciences are associated (or correlated) with PreveCeutical Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PreveCeutical Medical has no effect on the direction of Entia Biosciences i.e., Entia Biosciences and PreveCeutical Medical go up and down completely randomly.

Pair Corralation between Entia Biosciences and PreveCeutical Medical

Given the investment horizon of 90 days Entia Biosciences is expected to generate 17.19 times less return on investment than PreveCeutical Medical. But when comparing it to its historical volatility, Entia Biosciences is 1.83 times less risky than PreveCeutical Medical. It trades about 0.01 of its potential returns per unit of risk. PreveCeutical Medical is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  2.20  in PreveCeutical Medical on October 26, 2024 and sell it today you would lose (0.35) from holding PreveCeutical Medical or give up 15.91% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.2%
Values	Daily Returns

Entia Biosciences  vs.  PreveCeutical Medical

Entia Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Entia Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

PreveCeutical Medical

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in PreveCeutical Medical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, PreveCeutical Medical reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Entia Biosciences and PreveCeutical Medical

The main advantage of trading using opposite Entia Biosciences and PreveCeutical Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entia Biosciences position performs unexpectedly, PreveCeutical Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PreveCeutical Medical will offset losses from the drop in PreveCeutical Medical's long position.

The idea behind Entia Biosciences and PreveCeutical Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.